Trial
NCT02949492
Low-dose IL-2 for Treg Expansion and Tolerance (LITE)
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
King's College London
Collaborators
King's College Hospital NHS Trust
Condition
Transplantation
Intervention
IL-2 (interleukin 2)
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14